Search for a doctor

Jose N. Nativi Nicolau, M.D.

  1. Transplant Cardiologist
Request an Appointment

Publications

  1. Judge DP, Gillmore JD, Alexander KM, Ambardekar AV, Cappelli F, Fontana M, Garcia-Pavia P, Grodin JL, Grogan M, Hanna M, Masri A, Nativi-Nicolau J, Obici L, Hvitfeldt Poulsen S, Sarswat N, Shah K, Soman P, Lystig T, Cao X, Wang K, Pecoraro ML, Tamby JF, Katz L, Sinha U, Fox JC, Maurer MS. Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial. Circulation. 2025 Mar 4; 151 (9):601-611 Epub 2024 Nov 18
    View PubMed
  2. Rebello S, Hsu K, Nativi-Nicolau J, Karam C, Grogan M, Lousada I, Maurer MS. Factors associated with financial toxicity in patients with transthyretin amyloidosis: results from Amyloidosis Research Consortium's treatment affordability patient and caregiver survey. Amyloid. 2025 Feb 14; 1-10 [Epub ahead of print]
    View PubMed
  3. Lyle MA, Farina JMM, Wiedmeier-Nutor E, Lindpere V, Klanderman M, Nativi-Nicolau JN, Leoni Moreno JC, Goswami RM, Yip DS, Patel PC, Sher T, Rosenbaum AN, AbouEzzeddine OF, Boilson BA, Kushwaha SS, Clavell AL, Steidley DE, Hardaway BW, Scott RL, LeMond LM, Fonseca R, Gertz MA, Dispenzieri A, Grogan M, Rosenthal JL. Amyloidosis and Heart Transplantation in a New Era. Clin Transplant. 2025 Jan; 39(1):e70070.
    View PubMed
  4. Nativi-Nicolau J, Yilmaz A, Dasgupta N, Macey R, Cochrane J, Peatman J, Summers C, Luth J, Zolty R. Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review. J Comp Eff Res. 2024 Jul; 13 (7):e230158 Epub 2024 June 13
    View PubMed
  5. Sinclair De Frias J, Isha S, Olivero L, Raavi L, Narra SA, Paghdar S, Jonna S, Satashia P, Hannon R, Blasavage J, White L, Olanipekun T, Bansal P, Kiley S, Leoni JC, Nativi J, Lyle M, Thomas M, Sareyyupoglu B, Pham S, Smith M, Moreno Franco P, Patel P, Sanghavi D. Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched study. BMC Rheumatol. 2024 Feb 29; 8 (1):9
    View PubMed
  6. Gillmore JD, Judge DP, Cappelli F, Fontana M, Garcia-Pavia P, Gibbs S, Grogan M, Hanna M, Hoffman J, Masri A, Maurer MS, Nativi-Nicolau J, Obici L, Poulsen SH, Rockhold F, Shah KB, Soman P, Garg J, Chiswell K, Xu H, Cao X, Lystig T, Sinha U, Fox JC, ATTRibute-CM Investigators. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2024 Jan 11; 390 (2):132-142
    View PubMed
  7. Jang JM, Jarmi T, Sareyyupoglu B, Nativi J, Patel PC, Leoni JC, Landolfo K, Pham S, Yip DS, Goswami RM. Axillary mechanical circulatory support improves renal function prior to heart transplantation in patients with chronic kidney disease. Sci Rep. 2023 Nov 11; 13 (1):19671
    View PubMed
  8. Paghdar S, Desai S, Jang JM, Ruiz J, Malkani S, Patel P, Yip DS, Leoni JC, Nativi J, Sareyyupoglu B, Landolfo K, Pham S, Goswami RM. One-year survival in recipients older than 50 bridged to heart transplant with Impella 5.5 via axillary approach. J Geriatr Cardiol. 2023 May 28; 20 (5):319-329
    View PubMed
  9. Joury A, Faaborg-Andersen C, Quintana RA, daSilva-deAbreu A, Nativi-Nicolau J. Diagnostic Tools for Cardiac Amyloidosis: A Pragmatic Comparison of Pathology, Imaging and Laboratories. Curr Probl Cardiol. 2023 May; 48 (5):101106 Epub 2022 Jan 07
    View PubMed
  10. Malkani S, Nativi-Nicolau J. Insights on the first report of the Spanish registry of durable mechanical support (REGALAD). Rev Esp Cardiol (Engl Ed). 2023 Apr; 76 (4):218-219 Epub 2022 Oct 24
    View PubMed
  11. Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, Dember LM, Frantz JG, Hershberger RE, Maurer MS, Nativi-Nicolau J, Sanchorawala V, Sheikh FH, Writing Committee. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 Mar 21; 81 (11):1076-1126 Epub 2023 Jan 23
    View PubMed
  12. Sperry BW, Hanna M, Maurer MS, Nativi-Nicolau J, Floden L, Stewart M, Wyrwich KW, Barsdorf AI, Kapadia H, Spertus JA. Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. JAMA Cardiol. 2023 Mar 1; 8 (3):275-280
    View PubMed
  13. Carnicelli AP, Keane R, Brown KM, Loriaux DB, Kendsersky P, Alviar CL, Arps K, Berg DD, Bohula EA, Burke JA, Dixson JA, Gerber DA, Goldfarb M, Granger CB, Guo J, Harrison RW, Kontos M, Lawler PR, Miller PE, Nativi-Nicolau J, Newby LK, Racharla L, Roswell RO, Shah KS, Sinha SS, Solomon MA, Teuteberg J, Wong G, van Diepen S, Katz JN, Morrow DA. Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN). Resuscitation. 2023 Feb; 183:109664 Epub 2022 Dec 12
    View PubMed
  14. Brannagan TH 3rd, Berk JL, Gillmore JD, Maurer MS, Waddington-Cruz M, Fontana M, Masri A, Obici L, Brambatti M, Baker BF, Hannan LA, Buchele G, Viney NJ, Coelho T, Nativi-Nicolau J. Liver-directed drugs for transthyretin-mediated amyloidosis. J Peripher Nerv Syst. 2022 Dec; 27 (4):228-237 Epub 2022 Nov 16
    View PubMed
  15. Nativi-Nicolau J, Fine NM, Ortiz-Perez JT, Brown D, Vera-Llonch M, Reddy SR, Chang E, Tarbox MH. Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis. J Comp Eff Res. 2022 Oct; 11 (14):1031-1044 Epub 2022 Aug 22
    View PubMed
  16. Rozenbaum MH, Tran D, Bhambri R, Nativi-Nicolau J. Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy. Am J Cardiovasc Drugs. 2022 Jul; 22 (4):445-450 Epub 2022 Mar 30
    View PubMed
  17. Nativi-Nicolau JN, Karam C, Khella S, Maurer MS. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail Rev. 2022 May; 27 (3):785-793 Epub 2021 Feb 20
    View PubMed
  18. Nativi-Nicolau J, Judge DP, Hoffman JE, Gundapaneni B, Keohane D, Sultan MB, Grogan M. How did transthyretin amyloid cardiomyopathy progress in patients who took placebo in the study ATTR-ACT? A plain language summary. Future Cardiol. 2022 Mar 17 [Epub ahead of print]
    View PubMed
  19. Nativi-Nicolau J, Stehlik J, Kelkhoff AJ, Khong B, Truax CM, Revelo MP, Gilbert EM, Drakos S, Wever-Pinzon O, Fang J, Catino A, Khong HT. Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report. Transplant Proc. 2022 Jan-Feb; 54 (1):193-196 Epub 2022 Jan 07
    View PubMed
  20. Francisco MA, Lee JF, Barrett-O'Keefe Z, Groot HJ, Ratchford SM, Bunsawat K, Alpenglow JK, Ryan JJ, Nativi JN, Richardson RS, Wray DW. Locomotor Muscle Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. Hypertension. 2021 Dec; 78 (6):1750-1759 Epub 2021 Nov 01
    View PubMed
  21. Marashly Q, Taleb I, Kyriakopoulos CP, Dranow E, Jones TL, Tandar A, Overton SD, Tonna JE, Stoddard K, Wever-Pinzon O, Kemeyou L, Koliopoulou AG, Shah KS, Nourian K, Richins TJ, Burnham TS, Welt FG, McKellar SH, Nativi-Nicolau J, Drakos SG. Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score. Catheter Cardiovasc Interv. 2021 Dec 1; 98 (7):1275-1284 Epub 2021 Mar 07
    View PubMed
  22. Adams D, Algalarrondo V, Polydefkis M, Sarswat N, Slama MS, Nativi-Nicolau J. Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression. Orphanet J Rare Dis. 2021 Oct 3; 16 (1):411 Epub 2021 Oct 03
    View PubMed
  23. Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, Garcia-Pavia P, LoRusso S, Waddington-Cruz M, Lairez O, Witteles R, Chapman D, Amass L, Grogan M, THAOS Investigators. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey. JACC CardioOncol. 2021 Oct; 3 (4):537-546 Epub 2021 Oct 19
    View PubMed
  24. Bhatt AS, Berg DD, Bohula EA, Alviar CL, Baird-Zars VM, Barnett CF, Burke JA, Carnicelli AP, Chaudhry SP, Daniels LB, Fang JC, Fordyce CB, Gerber DA, Guo J, Jentzer JC, Katz JN, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Nativi-Nicolau J, Phreaner N, Roswell RO, Sinha SS, Jeffrey Snell R, Solomon MA, Van Diepen S, Morrow DA. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. J Card Fail. 2021 Oct; 27 (10):1073-1081
    View PubMed
  25. Nativi-Nicolau J, Judge DP, Hoffman JE, Gundapaneni B, Keohane D, Sultan MB, Grogan M. Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT. ESC Heart Fail. 2021 Oct; 8(5):3875-3884. Epub 2021 Aug 25.
    View PubMed
  26. Papolos AI, Kenigsberg BB, Berg DD, Alviar CL, Bohula E, Burke JA, Carnicelli AP, Chaudhry SP, Drakos S, Gerber DA, Guo J, Horowitz JM, Katz JN, Keeley EC, Metkus TS, Nativi-Nicolau J, Snell JR, Sinha SS, Tymchak WJ, Van Diepen S, Morrow DA, Barnett CF, Critical Care Cardiology Trials Network Investigators. Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams. J Am Coll Cardiol. 2021 Sep 28; 78 (13):1309-1317
    View PubMed
  27. Lawler PR, Berg DD, Park JG, Katz JN, Baird-Zars VM, Barsness GW, Bohula EA, Carnicelli AP, Chaudhry SP, Jentzer JC, Menon V, Metkus T, Nativi-Nicolau J, Phreaner N, Sinha SS, Teuteberg JJ, van Diepen S, Morrow DA, Critical Care Cardiology Trials Network Investigators. The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry. Crit Care Med. 2021 Aug 1; 49 (8):1293-1302
    View PubMed
  28. Rozenbaum MH, Large S, Bhambri R, Stewart M, Young R, Doornewaard AV, Dasgupta N, Masri A, Nativi-Nicolau J. Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy. J Comp Eff Res. 2021 Aug; 10 (11):927-938 Epub 2021 June 18
    View PubMed
  29. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J. Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol. 2021 Aug 1; 6 (8):957-962
    View PubMed
  30. Rozenbaum MH, Large S, Bhambri R, Stewart M, Whelan J, van Doornewaard A, Dasgupta N, Masri A, Nativi-Nicolau J. Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review. Cardiol Ther. 2021 Jun; 10 (1):141-159 Epub 2021 Apr 20
    View PubMed
  31. Garcia-Pavia P, Bengel F, Brito D, Damy T, Duca F, Dorbala S, Nativi-Nicolau J, Obici L, Rapezzi C, Sekijima Y, Elliott PM. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2021 Jun; 23 (6):895-905 Epub 2021 May 24
    View PubMed
  32. Brannagan TH 3rd, Auer-Grumbach M, Berk JL, Briani C, Bril V, Coelho T, Damy T, Dispenzieri A, Drachman BM, Fine N, Gaggin HK, Gertz M, Gillmore JD, Gonzalez E, Hanna M, Hurwitz DR, Khella SL, Maurer MS, Nativi-Nicolau J, Olugemo K, Quintana LF, Rosen AM, Schmidt HH, Shehata J, Waddington-Cruz M, Whelan C, Ruberg FL. ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. Orphanet J Rare Dis. 2021 May 6; 16 (1):204 Epub 2021 May 06
    View PubMed
  33. Rapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, Boman K, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT. JACC Heart Fail. 2021 Feb; 9 (2):115-123 Epub 2020 Dec 09
    View PubMed
  34. Nativi-Nicolau J, Sarswat N, Fajardo J, Finkel M, Abdulsattar Y, Castano A, Klein L, Haddad-Angulo A. Best Practices in Specialized Amyloidosis Centers in the United States: A Survey of Cardiologists, Nurses, Patients, and Patient Advocates. Clin Med Insights Cardiol. 2021; 15:11795468211015230 Epub 2021 May 29
    View PubMed
  35. Weavil JC, Thurston TS, Hureau TJ, Gifford JR, Kithas PA, Broxterman RM, Bledsoe AD, Nativi JN, Richardson RS, Amann M. Heart failure with preserved ejection fraction diminishes peripheral hemodynamics and accelerates exercise-induced neuromuscular fatigue. Am J Physiol Heart Circ Physiol. 2021 Jan 1; 320 (1):H338-H351 Epub 2020 Nov 08
    View PubMed
  36. Kang Y, Mondesir FL, Young D, Norris E, Hernandez JM, Nativi-Nicolau J, Stehlik J. Home Healthcare Nursing Visits for Nonhomebound Patients With Heart Failure After Hospital Discharge: A Quality-Improvement Pilot Project. Home Healthc Now. 2021 Jan-Feb 01; 39(1):25-31.
    View PubMed
  37. Gertz M, Adams D, Ando Y, Beirao JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam Pract. 2020 Sep 23; 21 (1):198 Epub 2020 Sept 23
    View PubMed
  38. Pregenzer-Wenzler A, Abraham J, Barrell K, Kovacsovics T, Nativi-Nicolau J. Utility of Biomarkers in Cardiac Amyloidosis. JACC Heart Fail. 2020 Sep; 8(9):701-711. Epub 2020 Jul 08.
    View PubMed
  39. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, Nair AP, Nativi-Nicolau J, Ruberg FL, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation. 2020 Jul 7; 142 (1):e7-e22 Epub 2020 June 01
    View PubMed
  40. Varshney AS, Berg DD, Katz JN, Baird-Zars VM, Bohula EA, Carnicelli AP, Chaudhry SP, Guo J, Lawler PR, Nativi-Nicolau J, Sinha SS, Teuteberg JJ, van Diepen S, Morrow DA, Critical Care Cardiology Trials Network Investigators. Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. JAMA Cardiol. 2020 Jun 01; 5(6):703-708.
    View PubMed
  41. Daud A, Mehra MR, Siu A, Johnson MR, Perch M, Budev M, Zakharia Y, Cheng R, Nativi-Nicolau J, Stehlik J. Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative. J Heart Lung Transplant 2020 Jun; 39 (6):604-606 Epub 2020 Apr 04
    View PubMed
  42. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O. Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC Heart Fail. 2020 Apr; 8 (4):302-312
    View PubMed
  43. Stehlik J, Schmalfuss C, Bozkurt B, Nativi-Nicolau J, Wohlfahrt P, Wegerich S, Rose K, Ray R, Schofield R, Deswal A, Sekaric J, Anand S, Richards D, Hanson H, Pipke M, Pham M. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020 Mar; 13 (3):e006513 Epub 2020 Feb 25
    View PubMed
  44. Wohlfahrt P, Zickmund SL, Slager S, Allen LA, Nicolau JN, Kfoury AG, Felker GM, Conte J, Flint K, DeVore AD, Selzman CH, Hess R, Spertus JA, Stehlik J. Provider Perspectives on the Feasibility and Utility of Routine Patient-Reported Outcomes Assessment in Heart Failure: A Qualitative Analysis. J Am Heart Assoc. 2020 Jan 21; 9 (2):e013047 Epub 2020 Jan 15
    View PubMed
  45. Berg DD, Barnett CF, Kenigsberg BB, Papolos A, Alviar CL, Baird-Zars VM, Barsness GW, Bohula EA, Brennan J, Burke JA, Carnicelli AP, Chaudhry SP, Cremer PC, Daniels LB, DeFilippis AP, Gerber DA, Granger CB, Hollenberg S, Horowitz JM, Gladden JD, Katz JN, Keeley EC, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Miller PE, Nativi-Nicolau J, Newby LK, Park JG, Phreaner N, Roswell RO, Schulman SP, Sinha SS, Snell RJ, Solomon MA, Teuteberg JJ, Tymchak W, van Diepen S, Morrow DA. Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry. Circ Heart Fail. 2019 Nov; 12 (11):e006635 Epub 2019 Nov 11
    View PubMed
  46. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2019 Sep; 12 (9):e006075 Epub 2019 Sept 04
    View PubMed
  47. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant. 2019 Aug; 38 (8):858-869 Epub 2019 Apr 20
    View PubMed
  48. Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, Grogan M, Selby VN, Jacoby D, Hanna M, Nativi-Nicolau J, Patel J, Rao S, Sinha U, Turtle CW, Fox JC. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. J Am Coll Cardiol. 2019 Jul 23; 74 (3):285-295 Epub 2019 Mar 15
    View PubMed
  49. Nativi J, Stehlik J, Al-Dulaimi R, Rodriguez C, Jaramillo J, Conte J, Kovacsovics T, Cowley J, Abraham J, Barrel K, Drakos S, Ryan J, Maurer MS, Fang J. Chronotropic incompetence and autonomic dysfunction as mechanisms of dyspnoea in patients with late stage cardiac amyloidosis Amyloid. 2019; 26(1):134-135.
  50. Ruiz-Negrón N, Nativi-Nicolau J, Maurer, Moran AE, Kovacsovics T, Bellows BK. Cost- effectiveness of technetium pyrophosphate scintigraphy versus heart biopsy for the diagnosis of transthyretin amyloidosis Amyloid. 2019; 26(1):71-72.
  51. Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, Nativi-Nicolau J, Stehlik J, Reid BB, Koliopoulou A, Stoddard GJ, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O. Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support. Circ Heart Fail. 2018 Nov; 11 (11):e005267
    View PubMed
  52. Nativi-Nicolau J, Maurer MS. Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types. Curr Opin Cardiol. 2018 Sep; 33 (5):571-579
    View PubMed
  53. Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik J. Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy. Circ Heart Fail. 2018 Aug; 11 (8):e004759
    View PubMed
  54. Varedi D, Kovacsovics T, Downs Kelly E, Abraham J, Cowley J, Barrell K, Revelo MP, Stehlik J, Drakos S, Marrouche N, Wilson B, Swanson EA, Fang J, Nativi-Nicolau J. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging. Circ Heart Fail. 2018 Jul; 11(7):e004812.
    View PubMed
  55. Barrett-O'Keefe Z, Lee JF, Berbert A, Witman MAH, Nativi-Nicolau J, Stehlik J, Richardson RS, Wray DW. Metaboreceptor activation in heart failure with reduced ejection fraction: Linking cardiac and peripheral vascular haemodynamics. Exp Physiol. 2018 Jun; 103 (6):807-818 Epub 2018 Apr 24
    View PubMed
  56. Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG. Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study. Circ Cardiovasc Imaging. 2018 Apr; 11 (4):e007117
    View PubMed
  57. Stehlik J, Rodriguez-Correa C, Spertus JA, Biber J, Nativi-Nicolau J, Zickmund S, Steinberg BA, Peritz DC, Walker A, Hess J, Drakos SG, Kfoury AG, Fang JC, Selzman CH, Hess R. Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study. J Card Fail. 2017 Nov; 23 (11):813-816 Epub 2017 Oct 02
    View PubMed
  58. Bonios MJ, Selzman CH, Gilbert EM, McKellar SH, Koliopoulou A, Strege JL, Nativi JN, Fang JC, Stehlik J, Drakos SG. Exertional Angina Due To Fused Aortic Bioprosthesis During Left Ventricular Assist Device Support: Two Cases and Review of the Literature. ASAIO J. 2017 Jan/Feb; 63 (1):e6-e9
    View PubMed
  59. AbouEzzeddine OF, Wong YW, Mentz RJ, Raza SS, Nativi-Nicolau J, Kociol RD, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM, NHLBI Heart Failure Clinical Research Network. Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. J Card Fail. 2016 Nov; 22 (11):853-858 Epub 2015 Dec 21
    View PubMed
  60. Grupper A, Nativi-Nicolau J, Maleszewski JJ, Geske JR, Kremers WK, Edwards BS, Kushwaha SS, Pereira NL. Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction. JACC Heart Fail. 2016 Nov; 4 (11):847-856 Epub 2016 Sept 07
    View PubMed
  61. Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J, Utah Transplant Affiliated Hospitals (U.T.A.H.) Cardiac Transplant Program. Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J Heart Lung Transplant. 2016 Aug; 35 (8):1024-30 Epub 2016 May 06
    View PubMed
  62. Lee JF, Barrett-O'Keefe Z, Nelson AD, Garten RS, Ryan JJ, Nativi-Nicolau JN, Richardson RS, Wray DW. Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction. Int J Cardiol. 2016 May 15; 211:14-21 Epub 2016 Mar 02
    View PubMed
  63. Witman, Garten, Gifford, Jonathan, Trinity, Stehlik, Nativi, Selzman, Drakos, Richardson. Peripheral Vascular Dysfunction Following Left Ventricular Assist Device Implantation: Insight from Passive Leg Movement Med Sci Sports Exerc. 2016; 48.
  64. Hammond MEH, Revelo MP, Miller DV, Snow GL, Budge D, Stehlik J, Molina KM, Selzman CH, Drakos SG, Rami A A, Nativi-Nicolau JN, Reid BB, Kfoury AG. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis. J Heart Lung Transplant. 2016 Mar; 35 (3):320-325 Epub 2015 Oct 30
    View PubMed
  65. Lee JF, Barrett-O'Keefe Z, Garten RS, Nelson AD, Ryan JJ, Nativi JN, Richardson RS, Wray DW. Evidence of microvascular dysfunction in heart failure with preserved ejection fraction. Heart. 2016 Feb 15; 102 (4):278-84 Epub 2015 Nov 13
    View PubMed
  66. Suksaranjit P, Ryan JJ, Han FT, Nativi-Nicolau J, Revelo MP, Wilson BD. Shortness of breath and cardiac conduction abnormality caused by infiltrative cardiomyopathy. Eur Heart J. 2015 Sep 1; 36 (33):2238 Epub 2015 May 28
    View PubMed
  67. Witman MA, Garten RS, Gifford JR, Groot HJ, Trinity JD, Stehlik J, Nativi JN, Selzman CH, Drakos SG, Richardson RS. Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility. JACC Heart Fail. 2015 Sep; 3 (9):703-11 Epub 2015 Aug 12
    View PubMed
  68. Wachter SB, McCandless SP, Gilbert EM, Stoddard GJ, Kfoury AG, Reid BB, McKellar SH, Nativi-Nicolau J, Saidi A, Barney J, McCreath L, Koliopoulou A, Wright SE, Fang JC, Stehlik J, Selzman CH, Drakos SG. Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator? Clin Transplant. 2015 Sep; 29 (9):829-34 Epub 2015 July 27
    View PubMed
  69. AbouEzzeddine OF, Haines P, Stevens S, Nativi-Nicolau J, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure). JACC Heart Fail. 2015 Mar; 3 (3):245-52
    View PubMed
  70. Abdallah, Deborah, Jose, Rami, M., H., Dylan. Antibody-mediated Rejection in Heart Transplantation Current Transplantation Reports. 2014; 1(4):246-256.
  71. Barrett-O'Keefe Z, Lee JF, Berbert A, Witman MA, Nativi-Nicolau J, Stehlik J, Richardson RS, Wray DW. Hemodynamic responses to small muscle mass exercise in heart failure patients with reduced ejection fraction. Am J Physiol Heart Circ Physiol. 2014 Nov 15; 307 (10):H1512-20 Epub 2014 Sept 26
    View PubMed
  72. Nativi-Nicolau J, Ryan JJ, Fang JC. Current therapeutic approach in heart failure with preserved ejection fraction. Heart Fail Clin. 2014 Jul; 10 (3):525-38
    View PubMed
  73. Nativi-Nicolau, Selzman, Fang, Stehlik. Pharmacological therapies for acute cardiogenic shock Curr Opin Cardiol. 2014; 29:250.
  74. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation. 2013 Jan 29; 127 (4):452-62 Epub 2012 Dec 27
    View PubMed
  75. Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-O'Keefe Z, Nativi JN, Stehlik J, Wray DW, Richardson RS. Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond. Hypertension. 2012 Sep; 60 (3):659-68 Epub 2012 July 02
    View PubMed
  76. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J. Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant. 2011 Dec; 11 (12):2755-61 Epub 2011 Sept 11
    View PubMed
  77. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2011 Aug; 30 (8):854-61 Epub 2011 May 14
    View PubMed
  78. Hayman MA, Nativi JN, Stehlik J, McDaniel J, Fjeldstad AS, Ives SJ, Walter Wray D, Bader F, Gilbert EM, Richardson RS. Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. Am J Physiol Heart Circ Physiol. 2010 Nov; 299 (5):H1653-9 Epub 2010 Sept 10
    View PubMed
  79. Nativi JN, Brown RN, Taylor DO, Kfoury AG, Kirklin JK, Stehlik J, Cardiac Transplant Research Database Group. Temporal trends in heart transplantation from high-risk donors: are there lessons to be learned? A multi-institutional analysis. J Heart Lung Transplant. 2010 Aug; 29 (8):847-52 Epub 2010 May 20
    View PubMed
  80. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik J. Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant. 2010 Mar; 29 (3):235-9 Epub 2009 Sept 26
    View PubMed
  81. Witman MA, McDaniel J, Fjeldstad AS, Ives SJ, Zhao J, Nativi JN, Stehlik, Wray DW, Richardson. A differing role of oxidative stress in the regulation of central and peripheral hemodynamics during exercise in heart failure Am J Physiol Heart Circ Physiol. 2002; 303(10):H1237-44.
PST-20521659